Annual Shareholders Equity
$486.95 M
+$231.74 M+90.80%
December 31, 2022
Summary
- As of February 10, 2025, PNT annual stockholders equity is $486.95 million, with the most recent change of +$231.74 million (+90.80%) on December 31, 2022.
- During the last 3 years, PNT annual shareholders equity has risen by +$473.47 million (+3512.34%).
Performance
PNT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$424.19 M
-$23.26 M-5.20%
September 30, 2023
Summary
- As of February 10, 2025, PNT quarterly stockholders equity is $424.19 million, with the most recent change of -$23.26 million (-5.20%) on September 30, 2023.
- Over the past year, PNT quarterly shareholders equity has increased by +$115.11 million (+37.24%).
Performance
PNT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PNT Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +90.8% | +37.2% |
| 3 y3 years | +3512.3% | - |
| 5 y5 years | +3512.3% | - |
PNT Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -47.6% | -12.9% | -49.2% |
| 5 y | 5-year | at high | -97.2% | -12.9% | -96.8% |
| alltime | all time | at high | -97.2% | -12.9% | -96.8% |
POINT Biopharma Global Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $424.19 M(-5.2%) |
| Jun 2023 | - | $447.45 M(-5.2%) |
| Mar 2023 | - | $471.78 M(-3.1%) |
| Dec 2022 | $486.95 M | $486.95 M(+57.5%) |
| Sep 2022 | - | $309.08 M(+43.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $215.38 M(-10.0%) |
| Mar 2022 | - | $239.27 M(-6.2%) |
| Dec 2021 | $255.21 M(+1793.2%) | $255.21 M(-5.1%) |
| Sep 2021 | - | $269.04 M(-5.8%) |
| Jun 2021 | - | $285.49 M(+2017.8%) |
| Dec 2020 | $13.48 M | $13.48 M |
FAQ
- What is POINT Biopharma Global annual stockholders equity?
- What is the all time high annual shareholders equity for POINT Biopharma Global?
- What is POINT Biopharma Global annual shareholders equity year-on-year change?
- What is POINT Biopharma Global quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for POINT Biopharma Global?
- What is POINT Biopharma Global quarterly shareholders equity year-on-year change?
What is POINT Biopharma Global annual stockholders equity?
The current annual shareholders equity of PNT is $486.95 M
What is the all time high annual shareholders equity for POINT Biopharma Global?
POINT Biopharma Global all-time high annual stockholders equity is $486.95 M
What is POINT Biopharma Global annual shareholders equity year-on-year change?
Over the past year, PNT annual stockholders equity has changed by +$231.74 M (+90.80%)
What is POINT Biopharma Global quarterly stockholders equity?
The current quarterly shareholders equity of PNT is $424.19 M
What is the all time high quarterly shareholders equity for POINT Biopharma Global?
POINT Biopharma Global all-time high quarterly stockholders equity is $486.95 M
What is POINT Biopharma Global quarterly shareholders equity year-on-year change?
Over the past year, PNT quarterly stockholders equity has changed by +$115.11 M (+37.24%)